JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
ESS Tech
GWH
$20.4M
| $265K | ﹤0.01% |
4,327
-26
| -0.6% | -$1.54K |
|
4577
Quad
QUAD
$513M
| $264K | ﹤0.01% |
103,036
-6,486
| -6% | -$21.2K |
|
|
OMIC
4578
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $264K | ﹤0.01% |
3,513
-812
| -19% | -$84.8K |
|
4579
Nature's Sunshine
NATR
$266M
| $263K | ﹤0.01% |
32,025
+7,072
| +28% | +$70.2K |
|
4580
SES AI
SES
$223M
| $263K | ﹤0.01% |
53,961
+16,786
| +45% | +$81.4K |
|
|
NWLI
4581
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $263K | ﹤0.01% |
1,533
+94
| +7% | +$18.3K |
|
4582
Adicet Bio
ACET
$78.4M
| $261K | ﹤0.01% |
1,147
+88
| +8% | +$22.3K |
|
4583
Tredegar Corp
TG
$276M
| $261K | ﹤0.01% |
27,691
-135,266
| -83% | -$1.4M |
|
|
SOND
4584
DELISTED
Sonder
SOND
| $260K | ﹤0.01% |
7,817
+4,435
| +131% | +$147K |
|
4585
Aspen Aerogels
ASPN
$485M
| $259K | ﹤0.01% |
28,137
+3,116
| +12% | +$37.7K |
|
4586
CALL
Campbell Soup
CPB
$6.91B
| $259K | ﹤0.01% |
5,500
| – | – |
|
4587
Sumitomo Mitsui Financial
SMFG
$167B
| $259K | ﹤0.01% |
47,071
+1,560
| +3% | +$9.41K |
|
4588
Bank of Marin Bancorp
BMRC
$458M
| $258K | ﹤0.01% |
8,632
+185
| +2% | +$5.88K |
|
4589
Vuzix
VUZI
$262M
| $258K | ﹤0.01% |
44,516
-25,440
| -36% | -$196K |
|
4590
Cullinan Oncology
CGEM
$1.31B
| $256K | ﹤0.01% |
19,909
+1,914
| +11% | +$25.8K |
|
|
GOEV
4591
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $256K | ﹤0.01% |
297
+44
| +17% | +$64.2K |
|
4592
Core Laboratories
CLB
$571M
| $255K | ﹤0.01% |
18,865
+9
| +0% | +$152 |
|
4593
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
| $255K | ﹤0.01% |
+5,983
| New | +$268K |
|
4594
iShares Core MSCI International Developed Markets ETF
IDEV
$32.7B
| $255K | ﹤0.01% |
5,289
+4,850
| +1,105% | +$261K |
|
4595
SmartRent
SMRT
$286M
| $255K | ﹤0.01% |
112,497
-9,481
| -8% | -$37.4K |
|
4596
PUT
Teck Resources
TECK
$31.2B
| $255K | ﹤0.01% |
8,400
| – | – |
|
|
VIEW
4597
DELISTED
View, Inc. Class A Common Stock
VIEW
| $255K | ﹤0.01% |
3,169
-277
| -8% | -$31.5K |
|
4598
CALL
VICI Properties
VICI
$29B
| $254K | ﹤0.01% |
8,500
| – | – |
|
|
4599
PUT
VICI Properties
VICI
$29B
| $254K | ﹤0.01% |
8,500
| – | – |
|
4600
Anika Therapeutics
ANIK
$288M
| $253K | ﹤0.01% |
10,606
+856
| +9% | +$19.7K |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.